144 related articles for article (PubMed ID: 23698517)
1. Incidental 11C-choline PET/CT brain uptake due to meningioma in a patient studied for prostate cancer: correlation with MRI and imaging fusion.
Bertagna F; Bosio G; Pinelli L; Treglia G; Giubbini R
Clin Nucl Med; 2013 Nov; 38(11):e435-7. PubMed ID: 23698517
[TBL] [Abstract][Full Text] [Related]
2. Incidental Meningioma Detected on 18F-Fluoride With PET/CT During Initial Staging for Prostate Cancer.
Teo TY; Menda Y; McNeely P; Kahn D; Graham M
Clin Nucl Med; 2015 Jul; 40(7):596-7. PubMed ID: 25899597
[TBL] [Abstract][Full Text] [Related]
3. Incidental 11C-choline PET/CT uptake due to esophageal carcinoma in a patient studied for prostate cancer.
Bertagna F; Bertoli M; Treglia G; Manenti S; Salemme M; Giubbini R
Clin Nucl Med; 2014 Oct; 39(10):e442-4. PubMed ID: 24561683
[TBL] [Abstract][Full Text] [Related]
4. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
Van den Bergh L; Koole M; Isebaert S; Joniau S; Deroose CM; Oyen R; Lerut E; Budiharto T; Mottaghy F; Bormans G; Van Poppel H; Haustermans K
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1486-92. PubMed ID: 22284686
[TBL] [Abstract][Full Text] [Related]
5. Incidental Detection of Meningioma by 18F-FMAU PET/CT in a Patient With Suspected Prostate Cancer.
Varghese B; Velez E; Desai B; Jadvar H
Clin Nucl Med; 2018 Jul; 43(7):e245-e246. PubMed ID: 29742600
[TBL] [Abstract][Full Text] [Related]
6. Incidental finding of parathyroid adenoma with 11C-choline PET/CT.
Mapelli P; Busnardo E; Magnani P; Freschi M; Picchio M; Gianolli L; Messa C
Clin Nucl Med; 2012 Jun; 37(6):593-5. PubMed ID: 22614195
[TBL] [Abstract][Full Text] [Related]
7. Incidental detection by [11C]choline PET/CT of meningiomas in prostate cancer patients.
Fallanca F; Giovacchini G; Picchio M; Bettinardi V; Messa C; Fazio F
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):417-21. PubMed ID: 19282812
[TBL] [Abstract][Full Text] [Related]
8. Imaging prostate cancer with 11C-choline PET/CT.
Reske SN; Blumstein NM; Neumaier B; Gottfried HW; Finsterbusch F; Kocot D; Möller P; Glatting G; Perner S
J Nucl Med; 2006 Aug; 47(8):1249-54. PubMed ID: 16883001
[TBL] [Abstract][Full Text] [Related]
9. [Pro and contra: 11C choline PET in diagnosis of prostate cancer].
Kotzerke J; Zöphel K; Salomon G; Graefen M; Heidenreich A
Aktuelle Urol; 2007 May; 38(3):189-94. PubMed ID: 17566231
[No Abstract] [Full Text] [Related]
10. 11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer.
Wachter S; Tomek S; Kurtaran A; Wachter-Gerstner N; Djavan B; Becherer A; Mitterhauser M; Dobrozemsky G; Li S; Pötter R; Dudczak R; Kletter K
J Clin Oncol; 2006 Jun; 24(16):2513-9. PubMed ID: 16636343
[TBL] [Abstract][Full Text] [Related]
11. Incidental finding of meningioma on C11-PIB PET.
Kim HY; Kim J; Lee JH
Clin Nucl Med; 2012 Feb; 37(2):e36-7. PubMed ID: 22228363
[TBL] [Abstract][Full Text] [Related]
12. A case of multimodality multiparametric 11C-choline PET/MR for biopsy targeting in prior biopsy-negative primary prostate cancer.
Takei T; Souvatzoglou M; Beer AJ; Drzezga A; Ziegler S; Rummeny EJ; Schwaiger M; Eiber M
Clin Nucl Med; 2012 Sep; 37(9):918-9. PubMed ID: 22889793
[TBL] [Abstract][Full Text] [Related]
13. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
Kitajima K; Murphy RC; Nathan MA; Froemming AT; Hagen CE; Takahashi N; Kawashima A
J Nucl Med; 2014 Feb; 55(2):223-32. PubMed ID: 24434294
[TBL] [Abstract][Full Text] [Related]
14. Index lesion characterization by (11)C-Choline PET/CT and Apparent Diffusion Coefficient parameters at 3 Tesla MRI in primary prostate carcinoma.
Hernández-Argüello M; Quiceno H; Pascual I; Solorzano JL; Benito A; Collantes M; Rodríguez-Fraile M; Pardo J; Richter JA
Prostate; 2016 Jan; 76(1):3-12. PubMed ID: 26390847
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience.
Thorwarth D; Henke G; Müller AC; Reimold M; Beyer T; Boss A; Kolb A; Pichler B; Pfannenberg C
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):277-83. PubMed ID: 21300465
[TBL] [Abstract][Full Text] [Related]
16. 11C-Choline and 18F-FDG PET/CT in the Detection of Occult Prostate Cancer in the Context of a Paraneoplastic Syndrome.
Jiménez-Bonilla J; Quirce R; Banzo I; Martínez-Rodríguez I; Carril JM
Clin Nucl Med; 2015 Aug; 40(8):695-6. PubMed ID: 26018697
[TBL] [Abstract][Full Text] [Related]
17. Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy.
Fuccio C; Castellucci P; Schiavina R; Santi I; Allegri V; Pettinato V; Boschi S; Martorana G; Al-Nahhas A; Rubello D; Fanti S
Ann Nucl Med; 2010 Jul; 24(6):485-92. PubMed ID: 20544323
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy.
Giovacchini G; Picchio M; Parra RG; Briganti A; Gianolli L; Montorsi F; Messa C
Clin Nucl Med; 2012 Apr; 37(4):325-31. PubMed ID: 22391699
[TBL] [Abstract][Full Text] [Related]
19. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].
García JR; Soler M; Blanch MA; Ramírez I; Riera E; Lozano P; Pérez X; Delgado E; Carrio I; Lomeña F
Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948
[TBL] [Abstract][Full Text] [Related]
20. 11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy.
Giovacchini G; Picchio M; Garcia-Parra R; Briganti A; Abdollah F; Gianolli L; Schindler C; Montorsi F; Messa C; Fazio F
J Nucl Med; 2014 Feb; 55(2):233-41. PubMed ID: 24408897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
